New insights into the role of cortisol and the glucocorticoid receptor in severe depression

Subgenual prefrontal cortex abnormalities in mood disorders

Drevets, W. C., Price, J. L., Simpson, J. R., Todd, R. D., Reich, T., Vannier, M., & Raichle, M. E. (1997) · Nature · doi:10.1038/386824a0 · Cited by 2,693

The Corticosteroid Receptor Hypothesis of Depression

Holsboer, F. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00159-7 · Cited by 2,181

Hippocampal atrophy in recurrent major depression

Sheline, Y. I., Wang, P. W., Gado, M. H., Csernansky, J. G., & Vannier, M. W. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.3908 · Cited by 1,932

Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety

Tronche, F., Kellendonk, C., Kretz, O., Gass, P., Anlag, K., Orban, P. C., Bock, R., Klein, R., & Schütz, G. (1999) · Nature Genetics · doi:10.1038/12703 · Cited by 1,841

Hippocampal Volume Reduction in Major Depression

Bremner, J. D., Narayan, M., Anderson, E. R., Staib, L. H., Miller, H. L., & Charney, D. S. (2000) · American Journal of Psychiatry · doi:10.1176/ajp.157.1.115 · Cited by 1,670

Depression Duration But Not Age Predicts Hippocampal Volume Loss in Medically Healthy Women with Recurrent Major Depression

Sheline, Y. I., Sanghavi, M., Mintun, M. A., & Gado, M. H. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-12-05034.1999 · Cited by 1,382 · cited 1×

Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states

Gold, P. W., & Chrousos, G. P. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001032 · Cited by 1,274

Anxiety and affective style: role of prefrontal cortex and amygdala

Davidson, R. J. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01328-2 · Cited by 1,170

The role of the medial prefrontal cortex (cingulate gyrus) in the regulation of hypothalamic-pituitary-adrenal responses to stress

Diorio, D., Viau, V, & Meaney, M. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-09-03839.1993 · Cited by 1,151

Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders

Drevets, W. C. (2001) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(00)00203-8 · Cited by 1,146

A systematic review of the mortality of depression

Wulsin, L. R., Vaillant, G. E., & Wells, V. E. (1999) · Psychosomatic Medicine · doi:10.1097/00006842-199901000-00003 · Cited by 703 · cited 1×

Glucocorticoids and the regulation of memory consolidation

Roozendaal, B. (2000) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(99)00058-x · Cited by 665

Dendritic reorganization in pyramidal neurons in medial prefrontal cortex after chronic corticosterone administration

Wellman, C. L. (2001) · Journal of Neurobiology · doi:10.1002/neu.1079 · Cited by 594

Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: Relation to hypercortisolism and corticotropin-releasing hormone

Wong, M., Kling, M. A., Munson, P. J., Listwak, S. J., Licinio, J., Prolo, P., Karp, B., McCutcheon, I. E., Geracioti, T. D., DeBellis, M. D., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.1.325 · Cited by 581

Working memory is more sensitive than declarative memory to the acute effects of corticosteroids: a dose-response study in humans

Lupien, S. J., Gillin, C. J., & Hauger, R. L. (1999) · Behavioral Neuroscience · doi:10.1037/0735-7044.113.3.420 · Cited by 561

Working memory is more sensitive than declarative memory to the acute effects of corticosteroids: A dose-response study in humans.

LUPIEN, S. J., Gillin, C. J., & Hauger, R. L. (1999) · Behavioral Neuroscience · doi:10.1037//0735-7044.113.3.420 · Cited by 556

Differential steroid hormone and neural influences on peptide mRNA levels in CRH cells of the paraventricular nucleus: a hybridization histochemical study in the rat

Swanson, L. W., & Simmons, D. M. (1989) · Journal of Comparative Neurology · doi:10.1002/cne.902850402 · Cited by 478

Distribution of glucocorticoid receptor immunoreactivity and mRNA in the rat brain: an immunohistochemical and in situ hybridization study

Morimoto, M., Morita, N., Ozawa, H., Yokoyama, K., & Kawata, M. (1996) · Neuroscience Research · doi:10.1016/s0168-0102(96)01105-4 · Cited by 475

Bone Mineral Density in Women with Depression

Michelson, D., Stratakis, C., Hill, L., Reynolds, J., Galliven, E., Chrousos, G., & Gold, P. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610173351602 · Cited by 471

Glucose metabolism in the amygdala in depression: relationship to diagnostic subtype and plasma cortisol levels

Drevets, W. C., Price, J. L., Bardgett, M. E., Reich, T., Todd, R. D., & Raichle, M. E. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00687-6 · Cited by 457

Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression

Raadsheer, F. C., van Heerikhuize, J. J., Lucassen, P. J., Hoogendijk, W. J. G., Tilders, F. J. H., & Swaab, D. F. (1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.9.1372 · Cited by 417

Control of neuronal excitability by corticosteroid hormones

Joëls, M., & de Kloet, E. R. (1992) · Trends in Neurosciences · doi:10.1016/0166-2236(92)90345-9 · Cited by 405

Corticosterone effects on corticotropin-releasing hormone mRNA in the central nucleus of the amygdala and the parvocellular region of the paraventricular nucleus of the hypothalamus

Makino, S., Gold, P. W., & Schulkin, J. (1994) · Brain Research · doi:10.1016/0006-8993(94)91862-7 · Cited by 400

Lateralized Effects of Medial Prefrontal Cortex Lesions on Neuroendocrine and Autonomic Stress Responses in Rats

Sullivan, R. M., & Gratton, A. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-07-02834.1999 · Cited by 377

Corticosterone delivery to the amygdala increases corticotropin-releasing factor mRNA in the central amygdaloid nucleus and anxiety-like behavior

Shepard, J. D., Barron, K. W., & Myers, D. A. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02019-9 · Cited by 321

An open label trial of C-1073 (mifepristone) for psychotic major depression*

Belanoff, J. K., Rothschild, A. J., Cassidy, F., DeBattista, C., Baulieu, E.-E., Schold, C., & Schatzberg, A. F. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01432-4 · Cited by 320

Depressed Mood and Other Psychiatric Manifestations of Cushingʼs Syndrome: Relationship to Hormone Levels

Starkman, M. N., Schteingart, D. E., & Schork, A. M. (1981) · Psychosomatic Medicine · doi:10.1097/00006842-198102000-00002 · Cited by 289

Effects of corticosterone on CRH mRNA and content in the bed nucleus of the stria terminalis; comparison with the effects in the central nucleus of the amygdala and the paraventricular nucleus of the hypothalamus

Makino, S., Gold, P. W., & Schulkin, J. A. (1994) · Brain Research · doi:10.1016/0006-8993(94)90961-x · Cited by 249

The effects of chronic administration of hydrocortisone on cognitive function in normal male volunteers

Young, A. H., Sahakian, B. J., Robbins, T. W., & Cowen, P. J. (1999) · Psychopharmacology · doi:10.1007/s002130051057 · Cited by 245

Loss of Brain Volume in Endogenous Cushing's Syndrome and Its Reversibility after Correction of Hypercortisolism

Bourdeau, I., Bard, C., Noël, B., Leclerc, I., Cordeau, M., Bélair, M., Lesage, J., Lafontaine, L., & Lacroix, A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.5.8493 · Cited by 240

The Amygdala: Corticotropin-Releasing Factor, Steroids, and Stress

Gray, T. S., & Bingaman, E. W. (1996) · Critical Reviews™ in Neurobiology · doi:10.1615/critrevneurobiol.v10.i2.10 · Cited by 230

Catecholamine effects upon rat hypothalamic corticotropin-releasing hormone secretion in vitro.

Calogero, A. E., Gallucci, W. T., Chrousos, G. P., & Gold, P. W. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113687 · Cited by 188 · cited 1×

Roles of type I and II corticosteroid receptors in regulation of basal activity in the hypothalamo-pituitary-adrenal axis during the diurnal trough and the peak: evidence for a nonadditive effect of combined receptor occupation.

Bradbury, M. J., Akana, S., & Dallman, M. (1994) · Endocrinology · doi:10.1210/endo.134.3.8119168 · Cited by 187

Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropinreleasing hormone

Wrong, M. (2000) · Medical Entomology and Zoology · Cited by 159

Stress-level cortisol treatment impairs inhibitory control of behavior in monkeys

Lyons, D. M., Lopez, J. M., Yang, C., & Schatzberg, A. F. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-20-07816.2000 · Cited by 144

Hippocampal homosynaptic long-term depression/depotentiation induced by adrenal steroids

Pavlides, C., Kimura, A., Magarin˜os, A. M., & Mcewen, B. S. (1995) · Neuroscience · doi:10.1016/0306-4522(95)94332-s · Cited by 126

Mice with targeted mutations of glucocorticoid and mineralocorticoid receptors: Models for depression and anxiety?

Gass, P., Reichardt, H. M., Strekalova, T. V., Henn, F. A., & Tronche, F. (2001) · Physiology & Behavior · doi:10.1016/s0031-9384(01)00518-2 · Cited by 121

Corticosteroid receptors in the brain: gene targeting studies

Kellendonk, C., Gass, P., Kretz, O., Schütz, G., & Tronche, F. (2002) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00638-4 · Cited by 113

Effect of corticosterone on the enhancement of the acoustic startle reflex by corticotropin releasing factor (CRF)

Lee, Y., Schulkin, J. A., & Davis, M. (1994) · Brain Research · doi:10.1016/0006-8993(94)90286-0 · Cited by 103

Effects of mineralocorticoid and glucocorticoid receptors on long-term potentiation in the CA3 hippocampal field

Pavlides, C., & McEwen, B. S. (1999) · Brain Research · doi:10.1016/s0006-8993(99)02188-5 · Cited by 103

Reduced Activity of Hypothalamic Corticotropin-Releasing Hormone Neurons in Transgenic Mice with Impaired Glucocorticoid Receptor Function

Dijkstra, I., Tilders, F. J. H., Aguilera, G., Kiss, A., Rabadan‐Diehl, C., Barden, N., Karanth, S., Holsboer, F., & Reul, J. M. H. M. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-10-03909.1998 · Cited by 69

Elevated endogenous cortisol reduces autonomic neuroendocrine and symptom responses to subsequent hypoglycemia

McGregor, V. P., Banarer, S., & Cryer, P. E. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00447.2001 · Cited by 66

1 Growth hormone deficiency and cardiovascular risk

Hew, F. L., O'Neal, D. N., Kamarudin, N., ALFORD, F. P., & Best, J. D. (1998) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(98)80018-9 · Cited by 46

Lesion of the Central Nucleus of the Amygdala Decreases Basal CRH mRNA Expression and Stress‐Induced ACTH Release

Prewitt, C. M., & Herman, J. P. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb39279.x · Cited by 34

High incidence of cardiovascular disease and increased prevalence of cardiovascular risk factors in women with hypopituitarism not receiving growth hormone treatment: Preliminary results

Erfurth, E. M., Bülow, B., ESKILSSON, J., & Hagmar, L. (1999) · Growth Hormone & IGF Research · doi:10.1016/s1096-6374(99)80005-7 · Cited by 31

Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies

Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,526

Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression

Drevets, W. C., Price, J. L., & Furey, M. L. (2008) · Brain Structure and Function · doi:10.1007/s00429-008-0189-x · Cited by 2,241

Neurocircuitry of Mood Disorders

Price, J. L., & Drevets, W. C. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.104 · Cited by 1,606

Psychobiological mechanisms of resilience and vulnerability: implications for successful adaptation to extreme stress

Charney, D. S. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.2.195 · Cited by 1,605

Discovering Endophenotypes for Major Depression

Hasler, G., Drevets, W. C., Manji, H. K., & Charney, D. S. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300506 · Cited by 1,123

Mifepristone as a Psychopharmacologic Agent: Consideration of Efficacy, Plasma Levels, and Mechanism of Action

Golier, J. A., & Yehuda, R. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.05.004 · Cited by 4

Mifepristone Plasma Level and Glucocorticoid Receptor Antagonism Associated With Response in Patients With Psychotic Depression

Block, T., Petrides, G., Kushner, H., Kalin, N., Belanoff, J., & Schatzberg, A. (2017) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000744 · Cited by 47

Clinical and Biological Effects of Mifepristone Treatment for Psychotic Depression

Flores, B. H., Kenna, H., Keller, J., Solvason, H. B., & Schatzberg, A. F. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300884 · Cited by 203

Combined Analysis of Mifepristone for Psychotic Depression: Plasma Levels Associated With Clinical Response

Block, T. S., Kushner, H., Kalin, N., Nelson, C., Belanoff, J., & Schatzberg, A. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.01.008 · Cited by 78

Reply: Clinical and Biological Effects of Mifepristone Treatment for Psychotic Treatment

Keller, J., & Schatzberg, A. F. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301171 · Cited by 6